A new tool predicts what genetics are truly driving the cancer in any population of cells and helps the user choose the best kinase inhibitor to address the issue.
Intravenous busulfan plus cyclophosphamide may be a valid and efficient alternative for patients with refractory acute myeloid leukemia.
Among long-term survivors of hematopoetic cell transplantation (HCT), patient-reported resilience is independently associated with outcomes.
Amgen's Blincyto costs about 178,000 for a standard course of treatment.
You research has shed light on the process by which mutated genes in leukemia reprogram blood stem cells and send them spiraling out of control.
Greatly improved outcomes have been observed in using stem cell transplantation to treat patients with juvenile myelomonocytic leukemia (JMML), a rare form of blood cancer.
Disparities in treatment outcomes for younger patients with acute promyelocytic leukemia (APL) exist.
Tyrosine kinase inhibitors (TKIs) seem safe in patients with chronic myeloid leukemia (CML) in chronic-phase and chronic kidney disease.
New compound that locks a disease-related protein into an inactive position stifled the growth of an aggressive form of leukemia.
Scientists have discovered that a common drug given to arthritis sufferers could also help to treat patients with blood cancers.
A recently developed drug holds great promise for some children with acute lymphoblastic leukemia (ALL).
An experimental new treatment approach could buy patients with a rare and dangerous leukemia type the time to obtain a stem cell transplant.
Can molecules derived from avocados be used as a tool to combat leukemia?
Majority of existing drugs for hematologic cancers are priced too high to be considered cost-effective in the United States.
The combination of ibrutinib and chemotherapy (bendamustine and rituximab [BR]) was found to reduce the risk of death by nearly 80% in patients with previously treated CLL or SLL.
Survey compares attitudes and beliefs toward palliative care among hematologic versus solid tumor specialists.
One more potential benefit for breastfed babies, research suggests, is a lowered risk of childhood leukemia.
A new meta-analysis of 26 factors has resulted in an internationally applicable prognostic index for patients with chronic lymphocytic leukemia, according to study results presented at 2015 ASCO Annual Meeting.
[Blood and Lymphatic Cancer: Targets and Therapy] The article discusses the history, use, and evolution of rituximab in the treatment of CLL and examines the next generation CD20 antibodies ofatumumab and obinutuzumab.
Transitioning a long-standing intensive chemotherapy regimen for acute myeloid leukemia (AML) to the outpatient setting is safe and feasible.
Researchers have developed a new drug that shows potential as a treatment for a rare type of acute leukemia, according to a recent study.
A mutation of the gene ETV6 has been pinpointed as the heritable, genetic cause of acute lymphoblastic leukemia (ALL), according to a study.
Researchers have developed a compound that delays leukemia in mice and kills leukemia cells in human tissue samples, which gives hope it could be used to improve regular leukemia therapy.
What data are available concerning inter- and intrapatient variability in the pharmacokinetics of TKIs in chronic myeloid leukemia?
A measurement of the concentration of leukemia cells in patient bone marrow during the first 46 days of chemotherapy may allow for better matching of patients to the optimal intensity of chemotherapy.
Current research indicates that a rare but aggressive subtype of pediatric acute lymphoblastic leukemia (ALL) has surprisingly few mutations beyond the chromosomal rearrangement that affects the MLL gene.
Acute lymphoblastic leukemia (ALL) has been found to have two distinct subtypes, and evidence indicates that roughly 13% of ALL cases may be successfully treated with targeted drugs used in the treatment of lymphomas in adults.
Breastfeeding a child may reduce that child's risk of developing pediatric acute lymphoblastic leukemia (ALL).
Presence of this protein indicates a likely toxicity effect associated with chemotherapy in acute myeloid leukemia (AML).
Children with acute lymphoblastic leukemia with a certain gene variant experienced a higher incidence and severity of peripheral neuropathy after receiving treatment with the cancer drug vincristine, according to a study.
- Study uses dog sledding to demonstrate benefits of adapted physical activities for children with cancer
- What are immune checkpoints and how do they work?
- Efficacy and safety of docetaxel for advanced non-small-cell lung cancer: A meta-analysis of Phase III randomized controlled trials
- Among patients with myeloma undergoing chemo, high exercise compliance linked with reduced fatigue
- Patients with advanced cancer prefer open, effective communication
- Religiousness and spirituality have a significant impact on cancer patients' overall health and outcomes
- Dietary intervention primes triple-negative breast cancer cells for targeted therapy
- Lung cancer patients who stop smoking live longer
- Review examines strategies for hospital room surface cleanliness
- Appropriate use of tomosynthesis mammography
- Counseling cancer survivors on family building options
- Imaging technique allows pediatric brain tumors to be classified noninvasively at diagnosis
- Antibiotic use was associated with increased risk for some cancers
- ADT impacts mood of patients with prostate cancer, as perceived by partners
- Varubi approved for nausea and vomiting associated with cancer chemo
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|